Novo Nordisk Has Recalled Novolin 70/30 InnoLet

The Food and Drug Administration (FDA) has released the following information.

PRODUCT
Novolin 70/30 InnoLet, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human
Insulin Injection (rDNA origin), 100 units/mL, 3mL Prefilled Insulin Syringes, Novo Nordisk.
Recall # D-062-3.

CODE
Lot # MS 60812 Exp. 6/2004
NDC# 0169-2317-21.

RECALLING FIRM/MANUFACTURER
Recalling Firm: Novo Nordisk Pharmaceuticals, Princeton, NJ, by fax on August 16, 2002.
Manufacturer: Novo Nordisk A/S Bagsvaerd, Denmark. Firm initiated recall is ongoing.

REASON
Defective container; delivery system may dispense less than the expected amount of insulin

VOLUME OF PRODUCT IN COMMERCE
83,789 units.

DISTRIBUTION
Nationwide and Puerto Rico.